A significant reduction in total cholesterol , low-density lipoprotein , and white blood cell count was observed during the study in the rosuvastatin group ( total cholesterol , from 4.820.90 to 4.430.77 mmol/l , P = 0.038 ; low-density lipoprotein , from 2.850.76 to 2.340.57 mmol/l , P = 0.006 ; white blood cell count , from 58101399 to 53551257/l , P = 0.048 ) , but not in the pravastatin group .